Skip to main content

ORIGINAL RESEARCH article

Front. Vet. Sci.
Sec. Oncology in Veterinary Medicine
Volume 11 - 2024 | doi: 10.3389/fvets.2024.1328058

Cancer detection in dogs using rapid Raman molecular urinalysis

 John L. Robertson1, 2*  Nikolaos Dervisis3, 4  John H. Rossmeisl3 Marlie Nightengale3 Daniel Fields3 Cameron Dedrick3  Lacy Ngo1 Amr S. Issa1, 2  Georgi Guruli5  GIUSEPPE ORLANDO6  Ryan S. Senger1, 2*
  • 1Virginia Tech, United States
  • 2Rametrix Technologies, Inc., United States
  • 3Virginia Maryland College of Veterinary Medicine, Virginia Tech, United States
  • 4Virginia Tech Carilion, United States
  • 5Virginia Commonwealth University Health System, United States
  • 6Wake Forest Baptist Medical Center, United States

The final, formatted version of the article will be published soon.

Receive an email when it is updated
You just subscribed to receive the final version of the article

The presence of cancer in dogs was detected by Raman spectroscopy of urine samples and chemometric analysis of spectroscopic data. Urine samples were collected via voiding, cystocentesis, or catheterization from 89 dogs with no history or evidence of neoplastic disease, 100 dogs diagnosed with cancer, and 16 dogs diagnosed with nonneoplastic urinary tract or renal disease. Raman spectra were obtained of the unprocessed bulk liquid urine samples and were analyzed by ISREA, principal component analysis (PCA), and discriminant analysis of principal components (DAPC) were applied using the Rametrix ® Toolbox software. The procedure created a multimolecular spectral fingerprint with hundreds of features related directly to the chemical composition of the urine specimen. These were then used to detect the broad presence of cancer in dog urine as well as the specific presence of lymphoma, urothelial carcinoma, osteosarcoma, and mast cell tumor. The procedure identified a spectral fingerprint for cancer in canine urine, resulting in a urine screening test with 92.7% overall accuracy for a cancer vs. cancer-free designation. The urine screen performed with 94.0% sensitivity, 90.5% specificity, 94.5% positive predictive value (PPV), 89.6% negative predictive value (NPV), 9.9 positive likelihood ratio (LR+), and 0.067 negative likelihood ratio (LR-). Raman bands responsible for discerning cancer were extracted from the analysis and biomolecular associations were obtained. The urine screen was more effective in distinguishing urothelial carcinoma from the other cancers mentioned above. Detection and classification of cancer in dogs using a simple, non-invasive, rapid urine screen (as compared to liquid biopsies using peripheral blood samples) is a critical advancement in case management and treatment, especially in breeds predisposed to specific types of cancer.

Keywords: Raman spectrocopy, Cancer, Lymphoma, Urine, Chemometric, Osteosarcoma, Mast cell tumor, Urothelial carcinoma (UC)

Received: 26 Oct 2023; Accepted: 18 Jan 2024.

Copyright: © 2024 Robertson, Dervisis, Rossmeisl, Nightengale, Fields, Dedrick, Ngo, Issa, Guruli, ORLANDO and Senger. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Mx. John L. Robertson, Virginia Tech, Blacksburg, 24061, Virginia, United States
Mx. Ryan S. Senger, Virginia Tech, Blacksburg, 24061, Virginia, United States